Some of the world’s biggest property investors are planning to spend billions of dollars on labs and offices for the booming life sciences sector. Tishman Speyer and biotechnology investment firm Bellco Capital have raised $3bn (£2.4bn) to develop and buy
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.